Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
Andrea Gaißler, Jonas Bochem, Janine Spreuer, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006802-e006802
Open Access | Times Cited: 11

Showing 11 citing articles:

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
Daniiar Dyikanov, A. V. Zaitsev, Т.В. Васильева, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 759-779.e12
Open Access | Times Cited: 23
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
Elena Splendiani, Zein Mersini Besharat, Alessia Covre, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108613-108613
Open Access | Times Cited: 17
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
Karama Asleh, Valerie Dery, Cathy Taylor, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis
Maximilian Möller, Vanessa Orth, Viktor Umansky, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives
S. Rajkumari, Jaspreet Singh, Usha Agrawal, et al.
International Immunopharmacology (2024) Vol. 142, pp. 112949-112949
Closed Access | Times Cited: 4
Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
Aiarpi Ezdoglian, M. Tsang-A-Sjoe, Fatemeh Khodadust, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
Crescenzo D’Alterio, Giuseppina Rea, Maria Napolitano, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Extracellular Vesicles: Diagnostic and Therapeutic Applications in Cancer
Maria Antonietta Di Bella, Simona Taverna
Biology (2024) Vol. 13, Iss. 9, pp. 716-716
Open Access | Times Cited: 2
Insights for the immunotherapy in malignant melanoma: a new revolution
Jiangying Xuan, Zixu Gao, Chuanyuan Wei, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Monocyte-Related Markers as Predictors of Immune Checkpoint Inhibitor Efficacy and Immune-Related Adverse Events: A Systematic Review and Meta-Analysis
Aiarpi Ezdoglian, M. Tsang-A-Sjoe, Fatemeh Khodadust, et al.
(2024)
Closed Access
Page 1

Scroll to top